What's on TV? Detecting age-related neurodegenerative eye disease using eye movement scanpaths by David P. Crabb et al.
ORIGINAL RESEARCH ARTICLE
published: 11 November 2014
doi: 10.3389/fnagi.2014.00312
What’s on TV? Detecting age-related neurodegenerative
eye disease using eye movement scanpaths
David P. Crabb*, Nicholas D. Smith and Haogang Zhu
Department of Optometry and Visual Science, School of Health Sciences, City University London, London, UK
Edited by:
Harriet Ann Allen, University of
Nottingham, UK
Reviewed by:
Jonathan Marotta, University of
Manitoba, Canada
Michael Wall, University of Iowa,
USA
*Correspondence:
Purpose: We test the hypothesis that age-related neurodegenerative eye disease can
be detected by examining patterns of eye movement recorded whilst a person naturally
watches a movie.
Methods: Thirty-two elderly people with healthy vision (median age: 70, interquartile
range [IQR] 64–75 years) and 44 patients with a clinical diagnosis of glaucoma (median
age: 69, IQR 63–77 years) had standard vision examinations including automated
perimetry. Disease severity was measured using a standard clinical measure (visual field
mean deviation; MD). All study participants viewed three unmodified TV and film clips
on a computer set up incorporating the Eyelink 1000 eyetracker (SR Research, Ontario,
Canada). Eye movement scanpaths were plotted using novel methods that first filtered the
data and then generated saccade density maps. Maps were then subjected to a feature
extraction analysis using kernel principal component analysis (KPCA). Features from the
KPCA were then classified using a standard machine based classifier trained and tested
by a 10-fold cross validation which was repeated 100 times to estimate the confidence
interval (CI) of classification sensitivity and specificity.
Results: Patients had a range of disease severity from early to advanced (median [IQR]
right eye and left eye MD was −7 [−13 to −5] dB and −9 [−15 to −4] dB, respectively).
Average sensitivity for correctly identifying a glaucoma patient at a fixed specificity of 90%
was 79% (95% CI: 58–86%). The area under the Receiver Operating Characteristic curve
was 0.84 (95% CI: 0.82–0.87).
Conclusions: Huge data from scanpaths of eye movements recorded whilst people freely
watch TV type films can be processed into maps that contain a signature of vision loss.
In this proof of principle study we have demonstrated that a group of patients with
age-related neurodegenerative eye disease can be reasonably well separated from a group
of healthy peers by considering these eye movement signatures alone.
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INTRODUCTION
The ever increasing elderly population will cause an “epidemic”
of age-related neurological disease in the 21st century. At present,
healthcare detection and monitoring of patients with sensory
impairments resulting from chronic age-related neurodegenera-
tive disease is done, mainly inadequately, in a clinic; a system
that is likely unsustainable in the future. Instead of relying on
infrequent tests in a clinic, focus should shift to capturing health-
related data acquired as part of a person’s ordinary daily activities.
Eye movements are a continuous and ubiquitous part of
sensory perception. Whenever we interact with the visual envi-
ronment we generate saccadic eye movements. Saccades move
the eyes in a ballistic fashion from one point to another, inter-
spersed by fixations where the eye is stable. Scanpaths, revealing
the sequence of fixations and saccades, collected non-invasively
during a period of time that a person is, for example, simply
engaged in watching a TV program could give an “eye movement
signature.” The main idea reported in this paper is to show how
these signatures could contain features that can be used to detect
if a person has a chronic neurodegenerative condition.
Glaucoma is a generic term for age-related disease of the optic
nerve which can lead to irreversible loss of the visual field: the
area which can be seen when the eye is directed forward, including
both central and peripheral vision. Medical treatment to control
the condition is largely successful, but once diagnosed all patients
with glaucoma normally need lifelong treatment, and lifelong
monitoring within hospitals and clinics, so that any worsening of
visual damage can be detected. Therefore, people with glaucoma
represent a major workload of eye services, with an estimated one
million outpatient appointments per year in the UK for exam-
ple (National Institute for Health and Clinical Excellence, 2009).
The visual field tests (perimetry) are often difficult for patients to
do and they are not done with sufficient frequency to adequately
monitor most patients (Chauhan et al., 2008; Fung et al., 2013;
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Glen et al., 2014). Moreover detection rates for the disease are
poor with an estimated 50% of all cases undetected (Rudnicka
et al., 2006).
In this work we use glaucomatous optic neuropathy as an
example of an age-related neurodegenerative disease (Yücel and
Gupta, 2008; Caprioli, 2013). The pathogenesis of glaucoma
shares many features with other chronic age-related neurode-
generative disease: there is, for example, ample evidence linking
the etiology and disease process in glaucoma to Alzheimer’s
disease (AD) (Bayer et al., 2002; Sivak, 2013). The epidemi-
ology and impact of glaucoma is well known but the patho-
genesis of the disease is multifaceted and not well understood.
Optic neuropathy is characterized in the clinic by changes in
the optic nerve head (ONH) and thinning of the nerve fiber
layer. This is almost certainly a result of a non-specific gradual
reactive change of glial cells resulting in chronic retinal gan-
glion cell death and then loss of visual function (Tezel and
Fourth ARVO/Pfizer Ophthalmics Research Institute Conference
Working Group, 2009; Sivak, 2013).
There are at least two theories to explain eye gaze. In short,
eye movement can be driven by factors that purposely direct fix-
ations toward task-driven locations or in the absence of such task
demands eyes are likely directed to salient regions. Investigators
have already used scanpaths to gain insights into what an observer
is doing or their mental state. For example, a large variety of stud-
ies have confirmed that eye movements contain rich signatures
about an observer. An excellent up-to-date review of the literature
is given elsewhere (Borji and Itti, 2014).
Investigators have revealed data showing that simple view-
ing patterns in controlled experiments can detect eye-movement
abnormalities that can discriminate schizophrenia cases from
control subjects with good accuracy (Benson et al., 2012). Other
workers, extracting salient features from a series of films, have
used eye movements to classify patients with attention deficit
hyperactivity disorder and Parkinson’s disease (Tseng et al., 2013).
The work of this type has attempted to demonstrate the classi-
fication of clinical populations from natural viewing. Errors in
the ability to make anti-saccades (an eye movement purposely
directed in the opposite direction from a target) has been repeat-
edly implicated in AD (Crawford et al., 2013) and patients with
AD have also been shown to display irregular eye movements
when reading and in other tasks (Lueck et al., 2000; Mosimann
et al., 2004). Our laboratory has published preliminary evidence
that patients with eye disease make different types of eye move-
ments when compared to age-related control subjects, when
performing different types of task (Crabb et al., 2010; Smith et al.,
2012; Glen et al., 2013). Other research regarding the nature and
consistency of the types of eye movement patterns shown by
groups of individuals as they view scenes have been considered
(Castelhano and Henderson, 2008; Cristino and Baddeley, 2009;
Dorr et al., 2010). Data analyses in these studies typically, and
inadequately, rely on simple counts and averages of, for exam-
ple, number of fixations, saccade amplitude, and region of interest
measures. We propose computational approaches to analyze eye-
tracking data not used before, considering sequences of saccades
within the scanpaths. We also apply machine classifiers to learn
combinations of multidimensional features extracted from the
scanpaths in order to discover patterns that belong to groups of
patients.
Therefore, in this study we test the hypothesis that age-
related neurodegenerative eye disease can be detected by exam-
ining patterns of eye movement recorded whilst a person nat-
urally watches a TV program. We do this with a case-control
study with the aim of providing evidence that patients with
a clinical diagnosis of glaucoma can be reasonably well sep-
arated from age-related healthy people using data from their
scanpaths alone.
MATERIALS AND METHODS
PARTICIPANTS
People with glaucoma were recruited from clinics at Moorfields
Eye Hospital NHS Foundation Trust, London. All patients had
an established clinical diagnosis of chronic open angle glaucoma
(COAG) for at least 2 years and were between 50 and 80 years of
age. COAG is defined, following clinical guidelines, by the pres-
ence of reproducible visual field defects in at least one eye with
corresponding damage to the ONH and an open iridocorneal
drainage angle on gonioscopy (National Institute for Health and
Clinical Excellence, 2009). The diagnosis was made by a glaucoma
specialist. A deliberate attempt was made to recruit a sample of
patients with a range of disease severity according to visual field
loss. Patients were purposely not recruited if they had any ocular
disease other than glaucoma (except for an uncomplicated lens
replacement cataract surgery). In addition, at the point of recruit-
ment, patients had slit lamp biomicroscopy performed by an
ophthalmologist to further exclude any other concomitant mac-
ular pathology, ocular surface disease or any significant problems
with dry eye.
Healthy people (controls), of a similar age to the patients, were
recruited from the City University London Optometry Clinic;
this is a primary care center where people routinely receive a full
eye examination, which includes measurement of visual acuity,
refraction, binocular vision assessment, pupil reactions, slit-lamp
assessment of the anterior eye, measurement of intraocular pres-
sure, visual field assessment and indirect ophthalmoscopy of the
macula, ONH, and peripheral retina. The City University London
Optometry Clinic is located just meters from the hospital mean-
ing all participants were drawn from an identical geodemographic
area.
All participants (patients and controls) were required to have a
corrected visual acuity of at least 0.18 logMAR (Snellen equivalent
6/9) in each eye at the time of their most recent examina-
tion. Astigmatic error was less than ± 2.5 Dioptres in all those
recruited. Participants were only recruited if they had no signif-
icant health problems (other than their glaucoma for patients),
meaning no difficulty with self-care, mobility, pain, anxiety, and
depression; this was ascertained at recruitment by self-report to
questions based on the EQ-5D instrument (Rabin and de Charro,
2001) added to the participation information sheet. Participants
were not enrolled if they were taking any significant medica-
tion other than that for their glaucoma. (“Significant medication”
included anti-depressants or treatment for diabetes or signifi-
cant use of β-blocker medication, all of which were deliberately
mentioned.) Recruitment of patients and controls was made
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simultaneously over a period of about 9 months with an effort
to make the two groups age-related.
The study was approved by the Moorfields and Whittington
Research Ethics Committee, London and the School of Health
Sciences Research and Ethics Committee, City University London.
Written informed consent, according to the tenets of the
Declaration of Helsinki, was obtained prior to examination from
each participant. Data was anonymized and stored in a secure
database.
SUPPLEMENTARY VISION TESTING AND COGNITIVE SCREENING
All participants underwent vision testing on the day of the
study. Visual fields were measured in both eyes with automated
perimetry using the Humphrey Field Analyzer (HFA; Carl Zeiss
Meditec, CA, USA) employing the central standard 24-2 Swedish
Interactive Testing Algorithm. This test is a clinical gold-standard
for measuring the severity of functional damage caused by glau-
coma. The Glaucoma Hemifield Test (GHT) on the HFA is
an established statistical test for early glaucomatous visual field
defects (Asman and Heijl, 1992). The GHT was “outside normal
limits” for all eyes in all patients and “within normal limits” for
all eyes in all controls. If any of the visual fields were flagged by the
HFA output as “unreliable,” as assessed by the false positive, false
negatives or poor fixation measures, then the test was repeated.
The HFA mean deviation (MD) is a standard clinical measure of
the overall severity of a visual field defect, relative to healthy age-
matched observers, with more negative values indicating greater
visual field loss (Flammer, 1986; Artes et al., 2011). MD values
were used as a measure of overall glaucomatous disease severity
in the patient group. Patients with MD better than −6 dB in both
eyes were classified as having early glaucomatous damage whilst
those with MD worse than −12 dB in both eyes were consid-
ered to have advanced disease; these patients would be typically
symptomatic and would, for example, likely fail the visual field
component for fitness to drive in the UK (Saunders et al., 2012).
All other patients would be considered to have moderate disease
severity. These values were taken from a widely used and well
established criterion for summarizing disease stages in glaucoma
(Hodapp et al., 1993; Mills et al., 2006).
Three other vision tests were performed on the day of the
experiment. Corrected binocular visual acuity (BVA) was mea-
sured using an Early Treatment Diabetic Retinopathy Study
(ETDRS) chart. All participants recorded BVA of at least 0.18
logMAR (Snellen equivalent of 6/9). We chose to restrict the
study to patients with preserved VA to allow for the impact of
glaucoma to be better isolated. Contrast sensitivity (CS) was
measured in log units with a Pelli-Robson chart. The Oculus
C-Quant straylight meter (Oculus GmbH, Wetzlar, Germany)
was used to measure abnormal light scattering in the eye
media, in order to eliminate significant media opacity and
other lens type artifacts as confounding ocular conditions; all
participants were required to be within “normal limits” for
this test.
All participants were examined with a modified version of
the Middlesex Elderly Assessment of Mental State (MEAMS,
Pearson, London, UK), a psychometric test designed to detect
gross impairment of specific cognitive skills such as memory and
object recognition in an elderly population. Each section of the
MEAMS is scored independently with lower scores indicating a
more significant cognitive impairment. The use of MEAMS for
screening of impairments has been validated by a number of
research studies (Morris et al., 2000). All participants passed the
MEAMS test. Individual scores (percent) were also recorded to
compare patients with controls.
MAIN EXPERIMENT
Participants viewed three separate unmodified TV and film clips
with sound on a 54 cm monitor (Iiyama Vision Master PRO 514,
Iiyama Corporation, Tokyo, Japan) at a resolution of 1600 by
1200 pixels (refresh rate 100Hz). One clip was an excerpt from
an entertainment program (309 sec; Dads Army, BBC Television)
which covered the full screen (subtending a half-angle of 20.3◦
by 14.9◦). The other two clips were taken from a feature film
(200 sec; The History Boys, 20th Century Fox) and a sports pro-
gram (436 sec; 2010Vancouver Winter Olympics Men’s Ski Cross,
BBC Television); both these clips were recorded at a 16:9 ratio,
therefore they contained black rectangles at the top and bot-
tom of the screen (subtended a half-angle of 17.3◦ by 10.6◦).
Participants were positioned, using a chin rest, at a viewing dis-
tance of 60 cm. The volume was kept at the same level throughout
all the trials and the films were in color. All participants wore
trial frames with a refractive correction suitable for the view-
ing distance of 60 cm to ensure that any obstruction to the
field of view caused by spectacle frames would be equivalent for
everyone.
Monocular eye movements were recorded at a temporal reso-
lution of 1000HZ during the task using an SR Research EyeLink
1000 (SR Research Ltd., Ontario, Canada). A purpose-written
application developed in C++ using Microsoft DirectShow was
used to display the video and link with the SR Research EyeLink
API. The eye giving the best quality pupil detection and corneal
reflection was chosen for tracking. The EyeLink proprietary algo-
rithm was used to calibrate and verify the participants’ point of
regard in relation to the correct location on the display. After
measuring fixation the default calibration technique monitors eye
movement to a stimulus presented at nine points on the mon-
itor. This process is repeated giving a measure of the validation
of the calibration. This process only took a few minutes at most.
Calibration accuracy flagged by the system to be of a “good” level
was a prerequisite before each trial. A drift correction was also
performed before each of the three films was displayed, and in the
case where a large drift (greater than 5◦) was detected, a recali-
bration performed. The films were shown in the same order for
all participants.
EYE MOVEMENT AND DATA ANALYSIS
The Eyelink 1000 gives average eye position accuracy of better
than 0.5◦ and uses velocity and acceleration thresholds of 30◦/s
and 8000◦/s2, respectively to identify saccades. This simple defi-
nition means smooth pursuits are excluded. Since the recordings
were done over a relatively long uninterrupted period of time
then it was not unusual for the eye tracker to lose the position
of the point of regard because of blinks and loss of pupil position.
In these instances the data is not useful. An automated filtering
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technique was applied to the collected data. A sliding window,
passing over the entire temporal eye movement trace associated
with each film for each person, counts the number of saccades
made per second. The percentage of 1 sec regions containing one
or more saccades is delineated per video clips per person and
labeled as “good” data. Any clip that contains less than 60% of
these regions of “good” data is excluded from the analysis. This
filtering was only used to exclude whole film clips. If a film clip
was included then all the available measured saccades made whilst
viewing it were used.
Next our software application builds a scanpath of saccades
and fixations for each person viewing each clip. From this a sac-
cade map is constructed on a grid of size 12◦ by 10◦ half angle
subdivided into 2◦ regions. This grid is populated with the end
position of every single saccade after it is assumed to be a vec-
tor starting at the origin (0, 0) on a Cartesian grid. Saccades with
end points falling outside this region are excluded. In addition,
the central 4 regions are excluded from the map thus remov-
ing indeterminable saccades of small amplitude. The frequency
distribution of the saccade endpoints across the entire map is
then recorded. This methodology is illustrated with the schematic
shown in Figure 1 and in a movie given in Supplementary
Material. For the next stage of the analysis we have a matrix of 116
values (10 × 20 with 4 central excluded values) for each video clip
for each person.
We first use kernel principal component analysis (KPCA)
to extract classifiable features from the saccade maps. KPCA is
widely used in pattern recognition and image processing prob-
lems (Scholkopf et al., 1999; Kwang In Kim et al., 2002; Jian Yang
et al., 2005). In short, KPCA is similar to PCA but it handles non-
linearities in the data by implicitly transforming data into high
dimensional feature space via the kernel function and then per-
forming a linear analysis in that space. The technique extracts
features in an unsupervised fashion meaning, from a practical
point of view, that none of the saccade maps are labeled as a case
or a control. The feature space in KPCA is defined by “kernels”
that quantifies the “distance” measure between every pair of par-
ticipants. Each saccade map is serialized to a 116 point vector and
the difference between participants on one video trial is defined
as the Euclidean distance between the two corresponding vectors.
The kernel kij between two participants i and j is then defined
as a non-normalized Gaussian distribution (1) where meanDiff
and maxDiff are the mean and maximum difference of all video
trials between the two participants:
kij = e−
1
2
(meanDiff+maxDiff )2
0.22 (1)
The kernel kij forms the KPCA feature Gram matrix K which is
then normalized and decomposed into principal eigenvectors, the
FIGURE 1 | A schematic illustrating how saccade maps are constructed
from one control participant viewing one video clip. The top row
shows frames from a video clip at a set time (green symbol shows a
fixation and blue line represents the preceding saccade). The saccade scan
path shows all saccades that have occurred up until that point in the
video. The centralized scan path shows how the saccade is treated as
vector starting at the origin (0, 0) on a Cartesian grid. The red lines
highlight saccades excluded for being either too large or too small. A
saccade heat map is created from the centralized saccade scan path: the
darker each location in the map, the larger the percentage of saccades
that ended in that region of the visual field (red regions represent excluded
locations). Each square is 2◦.
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importance of these is evaluated by ranking the corresponding
eigenvalues. The features for each person in our study are then
calculated as the projection onto these principal axes. Crucially we
then hypothesize that these “mathematical” features carry char-
acteristics that will allow us to efficiently separate the patients
from the controls on these data alone. In order to do this, signif-
icant features with the highest eigenvalues are input into a Naïve
Bayes linear classification algorithm. The classifier is trained and
tested by a 10 fold cross validation on all the data, repeated
100 times. In particular, with each iteration of the cross vali-
dation, 90% of the participants are randomly sampled to train
a Naïve Bayes model; the diagnostic performance of this model
is then tested on the remaining 10% participants. The average
sensitivity of the technique is then estimated (with 95% con-
fidence intervals) at fixed specificity using all iterations for the
entire sample of the data. These values are used to construct a
Receiver Operating Characteristic (ROC) curve summarizing the
classification potential of the methodology.
The analytical methods described were implemented in pur-
pose written programs using MATLAB R2013a (MathWorks Inc.,
Natick, MA).
RESULTS
Seventy-eight people were recruited and took part in the study.
We failed to acquire sufficient eye tracking data in two individ-
uals (both patients). Therefore, our study sample comprised 44
patients and 32 healthy people (controls) with mean age of 69
(standard deviation [SD]: 8) and 68 (SD: 9) years, respectively.
These means were not significantly different (two sample t-test;
P = 0.58) and the distribution of the ages were also equivalent
(F-test of variances; P = 0.35) meaning the groups represent age-
similar populations. Twenty-two of the patients (50%) and 17
controls (53%) were female. Glaucoma disease severity in the
patient group, as described by HFA MD in both eyes, is shown
in Figure 2; 9 (20%) and 11 (25%) of the patients had early and
advanced glaucomatous disease, respectively. Median (interquar-
tile range) right eye and left eye MD was −7 (−13 to −5) dB
and df−9 (−15 to −4) dB, respectively. Summary statistics for
the other vision and supplementary tests are shown in Table 1.
As expected CS differed between groups. The difference between
group BVA was statistically significant (P = 0.002) but the actual
size of the average difference was clinically small (95% CI for the
mean difference of 0.03–0.13), representing about 4 letters on the
chart, reflecting our minimum acuity inclusion criterion.
Saccade maps for every film clip for every participant are
given in Figure 3. In total 205 out of 234 (88%) film clips were
wholly included in the analysis. There was no statistically signifi-
cant difference (Chi-Squared Test; P = 0.43) between the average
inclusion rates for the controls (92%) and patients (86%).
An illustration of the results from the feature extraction, as
applied to the saccade maps, is given in Figure 4. Here the two
most significant features (eigenvectors, in arbitrary units) are
plotted against each other. This visualization hints at the good
separation achieved by considering the saccade maps alone when
the data is reduced to just two feature axes. KPCA revealed that
the five feature axes with the largest eigenvalues accounts for 35%
variance in the data. These five feature axes were then used in
FIGURE 2 | A graph showing the distribution of disease severity in the
patients. HFA MD values were used as a measure of overall glaucomatous
disease severity in the patient group. Patients with MD better than −6dB in
both eyes were classified as having early glaucomatous damage (green)
whilst those with MD worse than −12dB in both eyes were considered to
have advanced disease (red). All other patients would be considered to
have moderate disease severity (yellow). Two patients, excluded because
of sufficient eye tracking data, are shown as gray symbols.
Table 1 | Group summary statistics (mean [SD]) and comparison
(two-sample t-test) for ETDRS corrected binocular LogMAR visual
acuity (BVA), Pelli-Robson contrast sensitivity and MEAMS.
Patients Controls p-value
n = 44 n = 32
BVA (LogMAR) 0.02 (0.13) −0.06 (0.09) 0.002
CS (Log) 1.84 (0.18) 1.95 (0.00) <0.001
MEAMS (%) 97.9 (3.7) 98.1 (3.9) 0.82
the Naïve Bayes linear classification algorithm. An ROC curve
summarizing the “diagnostic precision” of the classifier is shown
in Figure 5. The area under the ROC curve is 0.85 (95% con-
fidence interval of 0.82–0.87). One point is highlighted on the
ROC curve since this illustrates that the technique has a sen-
sitivity (hit rate) of 76% (95% confidence interval of 58–86%)
at 90% specificity.
DISCUSSION
A whole series of visual and neurological processes coalesce in
order to allocate gaze efficiently. It therefore seems reasonable
that gaze patterns might be inhibited or be altered by visual and
neurological disorders. This simple notion underpins our driving
hypothesis that scanpaths from gaze patterns might be idiosyn-
cratic of neurodegenerative conditions. It might be that these
patterns can only be realized after examining an extensive period
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FIGURE 3 | Saccade maps for every video clip for every participant. A blue cross indicates a trial (video) that did not have enough valid eye movement data
according to the filtering process. These maps represent the entire data processed by the KPCA.
of recorded eye movements, but this is now possible with modern
eye tracking equipment and statistical methods that can inter-
pret the mass of scanpath data that is yielded by them. In this
case-control study we chose patients with one particular neurode-
generative eye disease. Gaze patterns were examined simply whilst
viewing everyday TV type films in a quite uncontrolled fash-
ion. The results from this study demonstrate proof of principle
for the effectiveness of our approach. Using novel methodology
we show that features extracted from extensive maps of saccades
made whilst watching TV clips can be quantified to correctly dif-
ferentiate a group of patients with a clinical diagnosis of glaucoma
from a group of age-similar healthy people. For example, at a rel-
atively high specificity (90%) we classified a patient in our sample
with sensitivity of 76% by using the saccade maps alone.
Some context for this estimate of “diagnostic accuracy” is
needed. There are three well-established index tests used to detect
glaucoma: intraocular pressure (IOP) measurements, visual field
tests and clinical assessments of the optic nerve. A systematic
review of the clinical effectiveness of detecting glaucoma reported
an enormous range for the estimates of diagnostic performance
in these tests (Burr et al., 2007; Mowatt et al., 2008). The pooled
estimates of the sensitivity of the clinically used tests in detect-
ing COAG ranged from as low as 42–92%, whilst specificity
ranged from 75 to 95%. Elevated IOP is only a risk factor for
disease but tonometry, the instrumentation used to assess high
IOP, is routinely used in primary care and case finding. The
lower estimates for diagnostic accuracy (∼ 40–50%) were for
IOP measures. Unsurprisingly those index tests reported to have
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FIGURE 4 | Scatterplot of participant data on the first two most
significant feature axes from the KPCA; this provides a visualization only
of the reasonable separation between patients and controls. Note the
classifier is blind to the diagnosis. Example saccade maps (right) from three
controls and four patients for all three videos in this study. The blue cross
represents a trial that does not have enough valid eye movement data
according to the filtering process. The symbols correspond to the location of
the subject in the scatterplot.
FIGURE 5 | An ROC curve summarizing the classification potential of
the methodology. The average sensitivity of the technique estimated (with
95% confidence intervals) at fixed specificity using all iterations for the
entire sample of the data is shown on the vertical axis. The red symbol
illustrates that the technique has a sensitivity of 76% (95% confidence
interval of 58–86%) at 90% specificity. The diagonal line is the classification
by chance.
better performance tended to be perimetric tests sharing direct
attributes with the reference standard. Methods for assessing the
ONH, either by direct observation by expert ophthalmologist or
an imaging device fare no better in detecting glaucoma, yielding
onlymodest accuracy when used in isolation. In one well reported
study, even expert ophthalmologists were shown to only classify
ONH photographs moderately well for detecting glaucoma with
diagnostic accuracy similar to what we report in our study (Reus
et al., 2010).
Our findings need to be discussed in the context of current
research. A catalog of research, extensively reviewed elsewhere,
suggests that laboratory recordings of eye movements can pro-
vide valuable information about neurodegenerative disease, and
hold promise as biomarkers for characterizing the efficacy of
neuroprotective and neurorestorative therapies (Anderson and
MacAskill, 2013). At the same time research findings about the
nature and consistency of gaze patterns shown by groups of indi-
viduals as they view scenes or films are somewhat mixed (Borji
and Itti, 2014). On the one hand, studies have shown that indi-
viduals within a group tend to produce similar eye movements
for the same movie of natural scenes; a finding thought to be
influenced by scene driven saliency effects whereby certain prop-
erties of the image cause individuals to produce a certain type
of eye movement (Itti, 2006; Cristino and Baddeley, 2009; Tatler
et al., 2011). Conversely, some studies have reported high levels
of variability of eye movements between subjects in response to
viewing scenes, which could be indicative of idiosyncratic view-
ing patterns within an individual (Andrews and Coppola, 1999;
Castelhano and Henderson, 2008), whilst others, for example,
have shown eye movements to natural images vary enormously
as a function of personality (Mercer Moss et al., 2012). More
recently other workers have pursued the effect of age in process-
ing video (Kirkorian et al., 2012). Others did not find evidence
for idiosyncratic viewing patterns of the same subject across
different movies (Dorr et al., 2010). Our study is most closely
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aligned with the attempts made to classify patients with atten-
tion deficit hyperactivity disorder, fetal alcohol spectrum disorder
and Parkinson’s disease using natural viewing eye movements
by Tseng et al. (2013). A novel computational model of visual
attention based on saliency properties of each frame of specifi-
cally constructed scene-shuffled videos was used as a benchmark
to predict gaze. By using a case-control study, similar in design
to ours, the investigators managed to classify a small group of
patients with acceptable levels of diagnostic accuracy. The inves-
tigators also used machine learning methods to analyses the eye
movement data and to classify the differences between predicted
gaze and actual gaze in the individuals (Tseng et al., 2013). Our
work differs because we did not build a model predicting where
people should look. Neither did we specifically select dynamic
content to be used. The novelty of our hypothesis rested on the
principal of demonstrating that patients could be separated from
controls where the dynamic content being viewed was not exten-
sively controlled. Our experimental effect was surprisingly large
given this condition.
The results from this study hint at important clinical appli-
cations and we speculate on these briefly now. Potential tests
of age-related neurological conditions, like glaucoma, based
on the concept formulated in this study would require lit-
tle patient action beyond the passive viewing of movies. Such
a procedure would have the potential to provide a continu-
ous assessment of changes either as the disease developed, or
during treatment, within a more realistic visual environment.
Moreover, eye tracking will likely become more affordable, prac-
tical, and robust in the near future, driven not by scientific
research but by demands of computer gaming, mobile technol-
ogy, and developments in human computer interaction. Our
contention is that anomalies in eye movements tracked dur-
ing viewing of naturalistic stimuli have the potential to be
developed into a rigorous test that could be incorporated into
an everyday activity, like something as simple as watching a
movie.
The experimental design of our study had several strengths.
The sampling was done carefully to ensure that the cases had the
same age, sex, and general health profile as the controls. All par-
ticipants passed the MEAMS test for cognitive ability and average
scores from this test did not differ between the two groups. Our
experimental design tried to eliminate other visual factors affect-
ing the results. For example, we chose to restrict the study to
patients with preserved visual acuity and healthy optical media
(assessed by straylight measures) to allow for the contribution of
functional loss due to glaucoma to be better isolated. In addi-
tion, the patients in this study had a range of disease severity
(Figure 2) adding to the strength of our findings. (Tests with
diagnostic promise become more sensitive as the disease becomes
more severe; a study including participants with advanced dis-
ease only would by default report better sensitivity.) Of course,
at this stage, it is very important to acknowledge results from
this preliminary case-control report do not even remotely sug-
gest that our method would translate into clinically significant
gains in the diagnostic precision of the disease; this must be
the subject of a study that must follow appropriate standards
(Bossuyt et al., 2003).
Our study had other notable novel attributes. For example, the
majority of eye movement studies reported in the literature have
been done on trained observers or young healthy volunteers: our
study clearly demonstrates that it is it is possible to collect exten-
sive eye movement data on elderly people; more than one quarter
of our participants were older than 75 years. Moreover, we took
advantage of modern statistical methods (KPCA) to assess the
high dimensional data yielded by the eye tracking. These methods
are unsupervised and “learn” the discriminatory features without
training on data that is labeled as “case” or “control.”
There are several limitations to our study. This proof of con-
cept study was designed to develop our method and test it on the
same material. It is well established that if modeling and testing
is done on the same data then model estimates of effects will
be overly optimistic. A far better experiment would have used
one sample of participants to develop the classifier and another
sample for testing. Our sample size was relatively small, although
large enough to demonstrate an effect. All the testing was done
on the same experimental set up; the repeatability of these results
on another experimental set up is unknown. The study included
no tests for attention deficits and so we cannot be sure that
the two groups would have had the same level of attention.
Furthermore, assessment for cognition was based on a modified
screening test only. Therefore, we cannot be certain that the two
groups would be the same had a more through cognitive exam-
ination been carried out. Two patients were excluded because
we could not extract meaningful scanpath data from them, and
this would be important if clinically meaningful estimates sensi-
tivity and specificity were being reported. Moreover, our results
and the paucity of data offer no real hint about what particular
characteristics of the saccade maps are suggestive of abnormality
and this awaits further study. Moreover, only patients with glau-
coma have been considered and we have no idea if these results
will translate to other age-related neurodegenerative conditions.
Furthermore, the pathogenesis of glaucoma shares many features
with other chronic age-related neurodegenerative disease but it
is not typically or primarily classified as such. The site of damage
histologically appears to be at the level of the ONH and is thought
to be due to the interaction of IOP, cerebrospinal fluid pressure,
ONH blood flow and changes in lamina cribrosa anatomy with
retinal ganglion cell changes being secondary.
In conclusion we have shown scanpaths of eye movements
recorded whilst people freely watch TV type films can be
processed into maps that contain a signature of age-related neu-
rological disease. In this proof of principle study we have demon-
strated that a group of patients with glaucoma can be reasonably
well separated from a group of healthy peers by considering
these eye movement signatures alone. Future studies will con-
sider larger groups of patients and other age-related neurological
disorders.
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